At last, a reason why stress causes DNA damage

August 21, 2011

For years, researchers have published papers that associate chronic stress with chromosomal damage.

Now researchers at Duke University Medical Center have discovered a mechanism that helps to explain the in terms of DNA damage.

"We believe this paper is the first to propose a specific mechanism through which a hallmark of , elevated adrenaline, could eventually cause DNA damage that is detectable," said senior author Robert J. Lefkowitz, M.D., James B. Duke Professor of Medicine and Biochemistry and a Howard Hughes Medical Institute (HHMI) investigator at Duke University Medical Center.

The paper was published in the Aug. 21 online issue of Nature.

In the study, mice were infused with an adrenaline-like compound that works through a receptor called the beta adrenergic receptor that Lefkowitz has studied for many years. The scientists found that this model of chronic stress triggered certain biological pathways that ultimately resulted in accumulation of DNA damage.

"This could give us a plausible explanation of how chronic stress may lead to a variety of human conditions and disorders, which range from merely cosmetic, like graying hair, to life-threatening disorders like malignancies," Lefkowitz said.

is a and is considered a "guardian of the genome" – one that prevents genomic abnormalities.

"The study showed that chronic stress leads to prolonged lowering of p53 levels," said Makoto Hara, Ph.D., a postdoctoral fellow in the Lefkowitz laboratory. "We hypothesize that this is the reason for the chromosomal irregularities we found in these chronically stressed mice."

Lefkowitz earlier had proved the existence of isolated, and characterized the G-protein-coupled receptors (GPCRs) such as the beta adrenergic receptor. These receptors, which are located on the surface of the membranes that surround cells, are the targets of almost half of the drugs on the market today, including beta blockers for heart disease, antihistamines and ulcer medications.

Now he is continuing studies along another pathway,stemming from the GPCRs, that was discovered in his lab, which is known as the beta-arrestin pathway. At first, the theory was that beta-arrestin proteins turned off or desensitized the G-protein pathways, but evidence is accumulating that these proteins are also responsible for causing certain biochemical activities in their own right.

In the current study, the scientists found a molecular mechanism through which adrenaline-like compounds acted through both G-protein and the beta-arrestin pathways to trigger DNA damage.

The Nature publication showed that the infusion of an adrenaline-like compound for four weeks in the mice caused degradation of p53, which was present in lower levels over time.

The study also showed that the DNA damage was prevented in mice lacking beta-arrestin 1. Loss of beta-arrestin 1 stabilized cellular levels of p53 both in the thymus, an organ that strongly responds to acute or chronic stress, and in the testes, where paternal stress might affect an offspring's genome.

Future studies planned by the Lefkowitz laboratory include studying mice that are placed under stress (restrained), thus creating their own adrenaline or stress reaction to learn whether the physical reactions of stress, rather than an influx of adrenaline in the lab as was done in the current study, also leads to accumulation of .

Explore further: Some antipsychotic drugs may be missing their mark

More information: The first author of the study, "Stress Response Pathway Regulates DNA Damage through β2-Adrenoreceptors and β-Arrestin-1," is Makoto R. Hara of Duke University.

Related Stories

Some antipsychotic drugs may be missing their mark

January 1, 2008

Drugs that treat depression, schizophrenia and other psychotic conditions and that target a particular protein on brain cells might not be triggering the most appropriate response in those cells, new research suggests.

Researchers Discover How Lithium Works

January 14, 2008

Despite more than 30 years of widespread use of lithium to control psychiatric disorders, such as bipolar disorder, scientists have been uncertain about how this drug actually works on a molecular level.

New target for heart failure therapy identified

March 16, 2009

A novel signaling pathway plays a significant role in the production of aldosterone, a hormone that promotes heart failure after a myocardial infarction, according to a study conducted by Thomas Jefferson University researchers.

New approach for growing bone

October 7, 2009

The natural cycle of building bone to maintain skeletal strength and then breaking it down for the body's calcium needs is delicately balanced, but diseases like osteoporosis break down too much bone without adequate bone ...

Recommended for you

New method creates endless supply of kidney precursor cells

August 25, 2016

Salk Institute scientists have discovered the holy grail of endless youthfulness—at least when it comes to one type of human kidney precursor cell. Previous attempts to maintain cultures of the so-called nephron progenitor ...

Strict diet combats rare progeria aging disorders

August 25, 2016

Mice with a severe aging disease live three times longer if they eat thirty percent less. Moreover, they age much healthier than mice that eat as much as they want. These are findings of a joint study being published today ...

New avenue for understanding cause of common diseases

August 25, 2016

A ground-breaking Auckland study could lead to discoveries about many common diseases such as diabetes, cancer and dementia. The new finding could also illuminate the broader role of the enigmatic mitochondria in human development.

7 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

NANOBRAIN
3.7 / 5 (3) Aug 21, 2011
I THINK THIS IS GOING TO BE VERY HELPFUL FOR HUMANITY.
Dug
not rated yet Aug 21, 2011
Undoubtedly associated with general inflammation as well.
0la_kala
not rated yet Aug 21, 2011
How do you think the mice feel about this Frankenstein?
We should restrain Lefkowitz and monitor his stress levels, but that would be unethical wouldn't it...Hmmm.
kevinrtrs
1 / 5 (1) Aug 22, 2011
Maybe we should allow "evolution" to take it's course....???

How did these wonderful chemical pathways develop at random, without killing the specimen in the first place? Another miracle for evolution to explain. Or NOT.
Ricochet
not rated yet Aug 22, 2011
If you want to relate it to "evolution" spin this around your brain...

If "God" didn't want us to tinker with stuff, we wouldn't have the desire to.
LuckyBrandon
not rated yet Aug 22, 2011
@kevinrts-ever notice how there are multiple sub-species of each and every species (including our own until ~30k years ago)? This would be evolution doing what you're talking about...

How do you think the mice feel about this Frankenstein?
We should restrain Lefkowitz and monitor his stress levels, but that would be unethical wouldn't it...Hmmm.


who cares, its a mouse...we can bring them back from the brink of extinction in a month due to their reproduction rate.....my pets rid the world of them of 2 per week, and there are always 100s more to replace them immediately....
Ricochet
not rated yet Aug 23, 2011
We should all sue our employers for corrupting our DNA with stressfull jobs.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.